Award
NIH Reporter #11168898
UAB Clinical Site HEAL Neonatal Opioid Withdrawal Pharmacological Treatments
Recipient
University of Alabama at Birmingham
Award Amount
$221,454.00
Ceiling
$221,454.00
Awarded
August 20, 2025
Identifier
11168898
A clinical trial at University of Alabama at Birmingham to evaluate the best pharmacological treatment for Neonatal Opioid Withdrawal Syndrome by comparing morphine, methadone, and buprenorphine.
Description
This project, conducted at the University of Alabama at Birmingham, aims to design and implement a multi-center, randomized controlled trial to assess the optimal pharmacological treatment for Neonatal Opioid Withdrawal Syndrome (NOWS). The study will compare morphine, methadone, and buprenorphine, considering non-pharmacologic factors and adjunct therapies.